A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia

Clinical trial NCT05883956 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05883956
Sponsor: Otsuka Australia Pharmaceutical Pty Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Leukemia, Myeloid, Acute Leukemia, Myelomonocytic, Chronic Patient Preference

Start date: 2023-12-20
Primary completion: 2024-12-06
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.